Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 3/20 | 0.42 |
| ▸ | MEN1 | O00255 | 2/20 | 0.42 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.41 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.41 |
| ▸ | LTA4H | P09960 | 4/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.34 |
| ▸ | HPGD | P15428 | 1/20 | 0.34 |
| ▸ | CNR2 | P34972 | 5/20 | 0.34 |
| ▸ | MAPT | P10636 | 2/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.33 |
| ▸ | HTT | P42858 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | BCHE | P06276 | 1/20 | 0.33 |
| ▸ | CNR1 | P21554 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5601407 | 0.88 | MEN1 (0.44) | KMT2AMEN1CHRNB2CHRNA4LTA4H | |
| SCHEMBL5601238 | 0.86 | POLB (0.39) | KMT2AMEN1CHRNB2CHRNA4LTA4H | |
| SCHEMBL5601356 | 0.85 | CHRNB2 (0.39) | KMT2AMEN1CHRNB2CHRNA4LTA4H | |
| SCHEMBL5599425 | 0.79 | PSMB1 (0.43) | KMT2AMEN1LTA4H | |
| SCHEMBL5600396 | 0.74 | POLB (0.40) | KMT2AMEN1MAPTLMNA | |
| SCHEMBL6650451 | 0.73 | LMNA (0.39) | KMT2AMEN1CHRNB2CHRNA4LTA4H | |
| SCHEMBL6654163 | 0.71 | HRH3 (0.35) | KMT2AMEN1CHRNB2CHRNA4L3MBTL1 | |
| SCHEMBL6650689 | 0.71 | L3MBTL1 (0.40) | KMT2AMEN1L3MBTL1MAPTLMNA | |
| SCHEMBL5599549 | 0.71 | L3MBTL1 (0.42) | KMT2AMEN1CHRNB2CHRNA4L3MBTL1 | |
| SCHEMBL6648700 | 0.71 | HRH3 (0.35) | KMT2AMEN1CHRNB2CHRNA4CNR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1103243-B1 | UTILIZATION OF ARYL(OR HETEROARYL)AZOLYLCARBINOL DERIVATIVES FOR THE TREATMENT OF TROUBLES MEDIATED BY AN EXCESS OF SUBSTANCE P | ESTEVE LABOR DR (ES) | 2004-01-07 | — | — | EP | claimed |
| EP-1755678-A2 | ACTIVE SUBSTANCE COMBINATION OF A CARBINOL COMPOUND AND AN OPIOID | LABORATORIOS DEL DR. ESTEVE, S.A. (ES) | 2007-02-28 | — | — | EP | disclosed |
| WO-2005097192-A2 | ACTIVE SUBSTANCE COMBINATION OF A CARBINOL COMPOUND AND AN OPIOID | LABORATORIOS DEL DR. ESTEVE, S.A. (ES) | 2005-10-20 | — | — | WO | disclosed |